FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Taysha Gene Therapies, Inc.: common_shares_outstanding

One fact, its scope and the complete path back to the official record.

Period: as of 2026-08-11Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/82735e2d-3e46-4371-be3a-941faabd427e

Reported value

325833545{"unit": "shares", "value": 325833545, "concept": "dei:EntityCommonStockSharesOutstanding"}
Entity
Taysha Gene Therapies, Inc.
Metric
common_shares_outstanding
Period
as of 2026-08-11
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-26-344610 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:11:55.955811+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001806310/common-shares-outstanding/2026-08-11 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.